London Quick Take - 5 Things to Know in Markets Today - 28 Oct
5 Things to Know in Markets Today
1.Budget: No drama, some fiction but fiscal headroom key to gilt market reaction
It seems clear that everything is pointing towards an early election in 2027. This explains why the Budget this year is looking so toned-down relative to Labour's big ambitions. Anything other than a 'steady-as-she-goes' event would be a surprise and arguably this means there is a low bar for an unfavourable market reaction. But a good reaction will help reduce the UK's 'moron premium'.
A headroom figure below £15bn probably gets punished by bond markets by increasing UK fiscal risk premia. Close to or above the £24bn left by Reeves will see gilt yields down. Ie, if headroom drives a fiscal-credibility repricing, under £15bn would favour bear steepening—long yields rising more than short yields. A credible £24bn+ cushion would favour bull flattening, with long gilts outperforming. Look out for a hefty issuance cadence from the OBR as potentially offsetting a positive reaction initially on fiscal headroom numbers. Though extra borrowing for things like the Your First Home scheme can be financed by bills rather than primary gilt issuance, the market would be sensitive to how much this sort-of-sleight-of-hand is used by the Chancellor to make the figures stack up.
I had a look at some of the major things to look at in the Budget here. I expect some movement in banks and other financials, defence stocks and housebuilders later depending on what comes out.
2.European stock market struggle to extend rally
Sterling sold off for a fourth straight down day ahead of the Budget after failing to hold the break above the 50-day line at the 1.340 round number..looks to be more about a recovery in the USD's fortunes than a pre-Budget verdict, but the pound will be sensitive to the Budget and the reaction in gilts.
3.AI rally builds after Anthropic IPO, SK Hynix earnings
High beta and momentum tech names were firmed with space, quantum and necloud stocks all rallying sharply, with Nebius +11%.
Coca-Cola rallied after hiking its full-year forecast for a third straight quarter despite some softness in US sales. The drinks company forecast earnings per share to grow at least 11%, from a prior forecast range of 9% to 10%.
Sellers remain in charge with Meta with the stock below both its 100-day moving average at $630.87 and its 200-day moving average at $632.33, a choke point that forms a key resistance area.
Boeing weighed on the Dow Jones sliding –10% on earnings miss with airline maker reporting Q3 Core EPS -$0.34 (est. -$0.21). Furthermore, FY26 deliveries guidance was cut, with 737 sales to below 500 (from 500), 787 to 90 (from 95-105). Management said to expect "stabilisation into early 2027", but it won’t significantly ramp up 737 Max production until late 2027.
Memory chip maker Seagate reported after the close - record quarter but shares fell –3% as strong momentum with revenues +61% not good enough it seems to satisfy.
Oracle shares rose after it revealed it is adding OpenAI’s ChatGPT and Codex to its application stack, extending enterprise access to OpenAI tools. Google TPUs, OpenAI’s Jalapeno chip and Cerebras hardware will also run on Oracle Cloud Infrastructure. Cerebras shares shot up 8% though they can't comment yet as it's in a quiet period.
Megacap tech earnings are the focus later with Alphabet and Microsoft delivering very important numbers.
4.Standard Chartered profit surges, Unilever and GSK shares dip
Standard Chartered shares rallied 3% to the top of the FTSE 100 after reporting a big rise in pre-tax profits in the third quarter and raised its full-year growth and profitability targets. Pre-tax profit jumped 27% to $2.25bn, ahead of a consensus estimate for a 12% rise. Unilever shares meanwhile sank -2% despite upgrading its full-year guidance on another solid quarter driven by volume. Underlying sales rose +5.2. Management guided up at least 3% underlying volume growth for FY26 and underlying sales growth of around 5% in H2 alongside some margin gains. GSK was also punished despite good-looking numbers. The drug company reported a 4% increase in Q3 sales to £8.9bn, led by growth in its Specialty Medicines business. Nevertheless shares were down -4% as third-quarter total operating profit fell 16% largely on a £328mn restructuring charge. Sales outlook looks good though.
5.Fed set to hold as RBNZ surprises
The kiwi dropped more than 1% after the Reserve Bank of New Zealand narrowly voted to leave interest rates on hold, against expectations. Meanwhile there is a huge gap in the AUDNZD, which jumped 1.5% on diverging monetary policy outlooks in New Zealand and Australia after Australian inflation accelerated in September, with headline CPI rising to 4.3% year-on-year from 4.0% in August. The Bank of Canada is expected to raise rates later today.
Get the full rundown of the week's key events here.